Syria Conflict Squeezes Drug Supplies for Major Diseases, WHO Says
This article was originally published in PharmAsia News
Executive Summary
Syria’s local production of medicines, once 90% of the nation’s consumption, has been greatly reduced by the civil war in the country, particularly in the provinces of Aleppo, Damascus and Homs where local drug makers tended to congregate.
You may also be interested in...
2019 Sees Decline In EMA Drug Approval Recommendations
The number of positive opinions given by the EMA’s CHMP has fallen to 66 this year from 84 in 2018.
Concessions Hit And Miss As Some UK Prices Treble
Concession prices granted by the UK Department of Health and Social Care targeted some, but not all, of the fastest-rising generics prices in November. The average cost of some presentations more than trebled, according to the latest figures from WaveData.
Reckitt Targets UK's Painful ‘Tweens’ With Double-Strength Nurofen
Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports